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Case Reportstroublesome and fibrillationmay afford an additional layer of
protection and allow more effective deairing in some cases.
Additional benefits from fibrillating the heart during pump
exchange are reduced blood loss from the apical inflow site
during pump exchange and decreased risk of blood contact
contamination of the operating team from an ejecting left
ventricle. Because most patients with an LVAD also have
an AICD in situ, we suggest that the method described here
is a simplemeans to induce,maintain, and reverse fibrillation.
Although dissecting out the base of the right ventricle to atta-
ch a fibrillator lead is also possible, this adds another layer of
complexity to the surgery with increased risk of bleeding and
injury to the heart, and risks unanticipated cardiac ejection if
wires are displaced and the heart beats spontaneously. By us-
ing theAICD to fibrillate, wewere able to keep the procedure
almost entirely within the LVAD pocket, making it truly
minimally invasive. Furthermore, as seen in our case, defi-
brillation by external pads may be difficult.From the Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical
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limited to LVAD device exchange, but could be extended
to other minimal access cardiac surgical procedures in pa-
tients who have AICDs. The approach may be useful in
such procedures, particularly where access to the heart is
limited, or where there is a desire to avoid aortic clamping,
such as mitral valve repair via thoracotomy in a patient with
previous coronary bypass grafts and depressed ventricular
function.
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and literature reviewWen-Jian Jiang, MD, Jin-Hua Li, MD, Jiang Dai, MD, and Yong-Qiang Lai, MD, Beijing, ChinaPrimary tumors and cysts of the heart and pericardium
are rare, and only 2.8% of these tumors are cardiac
hemangiomas.1 Ventricular hemangiomas are extremely
uncommon. We report one of these unusual cases and
discuss others in the literature.
CLINICAL SUMMARY
A 49-year-old man without symptoms was admitted to
our hospital. A mass between the right ventricle (RV) and
the pericardium was demonstrated on his chest computed
tomography (Figure 1, A). Transthoracic echocardiography
showed the mass to be located at the apex of the RV, and
there was no hemodynamic abnormality or RVoutflow tract
obstruction.The mass adjacent to the RV had a clear border with the
normal myocardium (Figure 1, B). It was totally excised
under cardiopulmonary bypass. A patch of autologous
pericardium covered with Dacron polyester fabric was
used for the reconstruction of the RV (Figure 1, C). This
patient recovered uneventfully, with no evidence of recur-
rence after 6 months of follow-up. The size of the mass
was 6.83 5.03 2.6 cm (Figure 1, D). Histologic diagnosis
was hemangioma (Figure 1, E).DISCUSSION
Primary tumors and cysts of the heart and pericardium
are rare, and only 2.8% of these tumors are cardiac
hemangiomas.1 Hemangiomas of the heart affect all ages
and may occur anywhere within the heart,2 but ventricular
hemangiomas are extremely uncommon. In 45 reviewed
cases of cardiac hemangioma, only 11 were located in the
RV.3 Cardiac hemangiomas are vascular tumors composed
of capillaries or cavernous vascular channels, and most
are benign.4 Surgery is the first choice of therapy in all pa-
tients with cardiac tumors.5
To date, 30 cases of hemangiomas located in the RV
(including that reported here) have been reported in the
literature. Table 1 shows the summary of preoperative
data and lists the surgical procedures in these cases. Theery c March 2014
FIGURE 1. A, Computed tomographic view shows a tumor mass (M) in the right ventricle (RV). B, After sternotomy, the tumor can be seen in the apex
of the right ventricle. C, Operative photograph shows the reconstruction of the right ventricle after the resection of the tumor with a graft patch (P).
D, Photograph shows a macroscopic view of the tumor, which was 6.8 3 5.0 3 2.6 cm. E, Photomicrograph shows a microscopic view of the tumor
(original magnification 3200). F, Fiber trabecular; S, sinusoids.
Case Reportsmost common sites were the anterior wall of the RV in
20 patients (66.7%), including the apex of the RV in
2 patients and the RV outflow tract in 10 others (33.3%).
Sotoda and colleagues6 reported the first cardiac heman-
gioma at the apex of the RV in 2008, and our case is the
second ever reported.
All 30 patients described in the literature underwent
operation. Cardiopulmonary bypass was used in 76.7% of
the cases. Total resection of the tumor was done in 83.3%
of cases, 88% with cardiopulmonary bypass. Surgical
outcome and follow-up information were available for 23
patients, whowere followed up for periods ranging between
6 months and 2 years; all were alive and well at follow-up.
Especially for the cardiac hemangiomas located in the
anterior wall of the RV, the reconstruction of cardiac
ventricle after the resection of the tumor, which is the
same as the procedure after the resection of ventricular
aneurysmectomy, is important, because heart failure
can result from low cardiac output.5 Because of the
reconstruction of the RV, postoperatively cardiac function
in our case was satisfactory.The Journal of Thoracic and CaConsidering all the points discussed here, we may safely
conclude that most cardiac hemangiomas in the RV are
located in the anterior wall, and these patients should
undergo reconstruction of the ventricle after resection
of the tumor under CPB. Long-term outcome seems
satisfactory, and little recurrence has been reported.References
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TABLE 1. Summary of preoperative data and details of surgical procedures in 30 cases of right ventricular hemangioma reported in the literature
Case
First author
and year
Age
(y) Sex
Clinical
presentation
Surgical
access Tumor site CPB
Surgical
procedure Outcome Pathology
1 Hochberg 1950 8 F Dyspnea Thoracotomy RV anterior wall,
pericardial pleura
N Total excision NA Cardiac hemangioma
2 Nicks 1964 20 F Dyspnea,
murmur
Sternotomy RV anterior wall,
RA anterior wall
Y Total excision NA Vascular hemangioma
3 Warembourg
1971
44 F Dyspnea,
murmur
Thoracotomy RV anterior wall N Total excision NA Cardiac hemangioma
4 Delaye 1972 23 M Dyspnea Sternotomy RVOT Y Total excision NA Hemangioendothelioma
5 Contamin 1973 20 F RH failure Sternotomy RV-LV-RA N No resection,
biopsy
NA Cardiac hemangioma
6 Thompson 1977 10 F RH failure,
murmur
Sternotomy RV-LV-PA N No resection,
biopsy
NA Cardiac hemangioma
7 Larrieu 1982 27 F Dyspnea,
murmur
Sternotomy RV anterior wall,
RA
N Total excision Alive and well Cardiac hemangioma
8 Novitzky 1984 59 F Pseudoangina Sternotomy RVOT Y Total excision Alive and well Cardiac hemangioma
9 Palmer 1986 43 M Arrhythmias Thoracotomy RV anterior wall,
Ao-PA
N No resection,
biopsy
Alive and well,
2 y
Cardiac hemangioma
10 Soberman 1988 3 M Murmur Sternotomy RVOT, septum Y Partial excision Alive and well,
1 y
Cardiac hemangioma
11 Matsutani T
1989
62 M RH failure Sternotomy RV anterior wall Y Total excision Alive and well Cardiac hemangioma
12 Golosovskaia
1990
17 M Dyspnea,
murmur
Sternotomy RV ant wall, septum Y Total excision Alive and well Cardiac hemangioma
13 Liao WH 1990 57 M Dull
chest pain
Sternotomy RVOT Y Total excision Alive and well,
7 mo
Cardiac hemangioma
14 Reiss N 1991 28 F Dyspnea,
murmur
Sternotomy RVOT Y Total excision Alive and well Cardiac hemangioma
15 Cunningham
1993
17 M Dyspnea,
murmur
Sternotomy RV anterior wall Y Total excision Alive and well Cardiac hemangioma
16 Ando M 1993 52 M NA Sternotomy RV anterior wall,
septum
Y Total excision Alive and well Cardiac hemangioma
17 Brizard 1993 24 M Dyspnea,
hepatalgia
Sternotomy RVOT, septum Y Total excision Alive and well,
1 y
Cardiac hemangioma
18 Gaires 1997 36 M NA Sternotomy RV anterior wall Y Total excision Alive and well Cardiac hemangioma
19 Harada 1998 74 M Dyspnea,
murmur
Sternotomy RV anterior wall,
septum
Y Total excision Alive and well Cardiac hemangioma
20 Kipfer 2000 74 M NA Sternotomy RV anterior wall Y Total excision Alive and well,
12 mo
Cardiac hemangioma
21 Ikeda 2001 56 M NA Sternotomy RV anterior wall Y Total excision Alive and well Cardiac hemangioma
22 Colli 2003 69 M NA Sternotomy RVOT Y Total excision Alive and well,
6 mo
Relapsed hemangioma
23 Arjomand 2004 61 F RH failure,
dyspnea
Sternotomy RV anterior wall Y Total excision Alive and well Cardiac hemangioma
24 Iba 2005 46 F Dizziness Sternotomy RVOT Y Total excision Alive and well Cardiac hemangioma
25 Turkoz 2005 61 F Palpitation
and
tightness
of chest
Sternotomy RV anterior wall,
RA
Y Total excision Alive and well,
14 mo
Cardiac hemangioma
26 Sotoda 2008 74 M NA Sternotomy Apex of RV Y Total excision Alive and well,
24 mo
Cardiac hemangioma
27 Botha 2010 65 F RH failure,
murmur
Sternotomy RV anterior wall N No resection,
biopsy
NA Cardiac hemangioma
28 Chen 2012 42 F Chest pain,
edema
Sternotomy RVOT Y Total excision Alive and well Cardiac hemangioma
(Continued)
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TABLE 1. Continued
Case
First author
and year
Age
(y) Sex
Clinical
presentation
Surgical
access Tumor site CPB
Surgical
procedure Outcome Pathology
29 Sogawa 2012 73 M NA Sternotomy RVOT Y Total excision Alive and well,
24 mo
Cardiac hemangioma
30 Jiang 2013 49 M NA Sternotomy Apex of RV Y Total excision Alive and well,
6 mo
Cardiac hemangioma
CPB, Cardiopulmonary bypass; F, female; RV, right ventricle;NA, not available; RA, right atrium;M, male; RVOT, right ventricular outflow tract; RH, right heart; LV, left ventricle;
PA, pulmonary artery; Ao, aorta.
Case ReportsFunctioning Cooley-Cutter aortic valve prosthesis 40 years
after implantationSahar A. Saddoughi,a Daniel H. Steinberg, MD,b and John S. Ikonomidis, MD, PhD,a Charleston, SCVideo clip is available online.
The development of artificial heart valves has revolution-
ized cardiac surgery. During the past 60 years, heart valve
prostheses have evolved considerably, with each newmodel
designed with the hope of better hemodynamics and
outcomes for patients. The Cooley-Cutter heart valve
was designed in the 1960s by Denton A. Cooley, MD,
in collaboration with Cutter Laboratories and introduced
for clinical use in 1971.1 The device used 2 sets of
titanium struts to contain a biconic occluder composed of
pyrolytic carbon. Cooley-Cutter heart valves were used
frequently in the 1970s,2 with Dr Cooley alone having
implanted the device in a total of 3275 patients (1786 in
the aortic position and 1475 in the mitral) over a 10-year
period, with very good clinical results.3 Since that time,
newer mechanical valves have replaced the Cooley-Cutter
valve.
CLINICAL SUMMARY
An 85-year-old man with a medical history significant for
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previous mechanical aortic valve replacement was seen
for dyspnea on exertion and minor weight loss. The
patient’s surgical history was significant for aortic valve
replacement with a Cooley-Cutter prosthesis, implanted
by Dr Cooley at the Texas Heart Institute on October 4,
1973. Results of physical examination were unremarkable;
cardiac examination revealed regular rate and rhythm with
S1 and S2, no S3 or S4, and no appreciable murmurs, rubs,
or gallops.
Transthoracic echocardiography (Figure 1) showed an
intact aortic valve replacement. The valve was properly
seated with normal occluder motion. The peak transvalvular
velocity was 3.4 m/s, with a mean gradient of 24 mm Hg.
The left ventricular ejection fraction was calculated to
be 60%.DISCUSSION
A recent single-center retrospective review of the results
of the use of the St Jude mechanical valve4 demonstrated a
25-year survival of 17%  4%. In the context of these
results, it is high unusual to document such excellent func-
tional results as those of this 40-year-old Cooley-Cutter
prosthesis. Another mechanical aortic valve prosthesis
that has been shown to be remarkably durable in certain
cases is the Starr-Edwards prosthesis.5 Our patient’s
symptoms were ultimately found to be unrelated to his
cardiac history, and he currently remains well controlled
on warfarin. Overall, the prosthetic valve remains in
excellent condition with no need for replacement.References
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